Navigation Links
Corporate control begins with a strong board

Editor's note: This is the second in a three-part series of op-ed pieces on corporate governance. The articles, part of WTN Media's Boardroom Perspectives column, are written by associates in the Madison-based public accounting firm Candela Solutions, LLC.

Question: What is the most important corporate con......

Full article >>> ance.html">Section 404 of SOX is on financial reporting controls. Unfortunately for many companies, this often means rearranging priorities at the expense of operational controls. Keep in mind that SOX-404's focus is on the accuracy and completeness of financial statements, not on the company's profitability, customer satisfaction, or any other operational objective. Consequently, a huge oppor......

Full article >>> nition of internal control.

Yet, in many companies, boards continue to trek down a risky slope due to misconceptions of their role and the lack of healthy skepticism in their CEO, who may also serve as chairman of the board. Here are five key principles that strong boards should follow in promoting a healthy control environment:

Recruit a multi-disciplined group of competent dir......

Full article >>> s="AuthorBio">Ron Kral is a partner with Candela Solutions. He can be reached at rkral@candelasolutions.com.

The opinions expressed herein or statements made in the above column are solely those of the author, and do not necessarily reflect the views of the Wisconsin Technology Network, LLC. WT......

Full article >>>
'"/>

Source:wistechnology.com By Ron Kral 12/12/06


Related biology technology :

1. Corporate Social Responsibility - Burden, sham, or golden opportunity?
2. Corporate venturing can nurture software success
3. Corporate clients will dominate surge in nanotech tool demand, study projects
4. Corporate name change challenges
5. Corporate Americas hidden deficit
6. Corporate identity fitness test
7. UW Office of Corporate Relations nears one-year mile-mark
8. UW Office of Corporate Relations Celebrates Early Accomplishments
9. Sonic Foundry CEO Predicts the Corporate Enterprise Will Be the Linchpin for Rich Medias Growth Surge at Streaming Media 2003
10. Quality control of antibodies using the 2100 bioanalyzer and the Protein 200 Plus assay
11. Using the Agilent 2100 bioanalyzer for quality control of protein samples prior to MS-analysis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/23/2017)... Baltimore, Maryland (PRWEB) , ... ... ... firm, PathSensors, Inc., announced today that in a published evaluation of multiple ... (PNNL), a U.S. Department of Energy Laboratory, PathSensors’ CANARY® biosensor threat detection ...
(Date:2/23/2017)... ... ... The Greater Gift Initiative, Inc , (GGI) a Winston-Salem, NC 501(c)3 non-profit, ... is to advance global health and highlight the greater good of clinical trial participation ... trial volunteer. The vision of GGI is to serve as a philanthropic connector between ...
(Date:2/23/2017)... and SAN FRANCISCO , ... privately-held regenerative medicine company, and Beyond Type 1, a ... type 1 diabetes, today announced a grant from Beyond ... functional cure for type 1 and other insulin-requiring diabetes.  ... has been developing innovative stem cell-derived cell replacement therapies ...
(Date:2/22/2017)... ... February 22, 2017 , ... Kernel ... Kendall Research Systems, LLC (KRS) clinical development program. KRS is a neurotechnology ... for research and clinical applications. The terms of the transaction were not disclosed. ...
Breaking Biology Technology:
(Date:2/7/2017)... , Feb. 7, 2017   MedNet Solutions ... the entire spectrum of clinical research, is pleased to ... , its innovative, highly flexible and award winning ... customers. iMedNet is a proven Software-as-a-Service ... Electronic Data Capture (EDC), but also delivers an entire ...
(Date:2/6/2017)... , Feb. 6, 2017 According to ... are driving border authorities to continue to embrace ... there are 2143 Automated Border Control (ABC) eGates ... deployed at more than 163 ports of entry ... to 2016 achieving a combined CAGR of 37%. ...
(Date:2/2/2017)... 2017   TapImmune, Inc. (NASDAQ: ... in the development of innovative peptide and gene-based ... and metastatic disease, announced today it has successfully ... a second clinical lot of TPIV 200, the ... The manufactured vaccine product will be used to ...
Breaking Biology News(10 mins):